middle.news
Firebrick wins Philippine OTC approval for Nasodine with Q1 2027 launch possible
8:24am on Friday 16th of October, 2026 AEDT
•
Consumer Healthcare
Read Story
Firebrick wins Philippine OTC approval for Nasodine with Q1 2027 launch possible
8:24am on Friday 16th of October, 2026 AEDT
Key Points
Philippines Food and Drug Administration approval secured
Nasodine classified as an over-the-counter antiseptic
Potential commercial launch as early as Q1 2027
Initial approval valid until 24 September 2028
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Firebrick Pharma (ASX:FRE)
OPEN ARTICLE